PRM — Big Pharma Split Corp A Shares | ScreenerHero

PRMBig Pharma Split Corp A Shares

TSX · CA · Financials · Capital Markets

13.85CAD+0.65%Mkt Cap: 16.84M CADP/E: —Last update: 2026-05-26

Industry Peers

Capital Markets

316.98BUSDP/E 18.2

The Goldman Sachs Group, Inc.

291.94BUSDP/E 18.1

The Charles Schwab Corporation

156.41BUSDP/E 17.9

Interactive Brokers Group, Inc.

140.68BUSDP/E 35.5

Nordnet AB (publ)

81.27BSEKP/E 27.2

Robinhood Markets, Inc.

66.42BUSDP/E 35.8

Is Yatirim Menkul Degerler Anonim Sirketi

57.60BTRYP/E 8.4

LPL Financial Holdings Inc.

22.57BUSDP/E 25.4

Indicators:|

Key Statistics

Company

Market Cap16.84M CAD

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)12.91K CAD

Revenue/Share—

Last Price13.85 CAD

Fiscal Year End—

MR Quarter—

Employees—

CountryCA

SectorFinancials

IndustryCapital Markets

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B1.25

EPS (TTM)—

EPS (Forward)—

52W Range

10.7166% of range15.50

52W High15.50 CAD

52W Low10.71 CAD

Profitability

Gross Margin—

Oper. Margin—

EBITDA Margin—

Profit Margin2.97%

ROE0.09%

ROA0.05%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF1.71M CAD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio—

Quick Ratio—

Book Value/Sh10.81 CAD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate1.237 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay DateMay 6, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.22M

Float—

Insiders—

Institutions—

Technical

SMA 5013.84 (+0.1%)

SMA 20013.29 (+4.2%)

Beta—

S&P 52W Chg—

Avg Vol (30d)2.65K

Avg Vol (10d)1.38K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—